Profile | GDS5420 / 223256_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 363.94 | 62 |
GSM1296119 | B_lesional_pre-dose | 352.91 | 62 |
GSM1296076 | C_lesional_pre-dose | 348.87 | 63 |
GSM1296092 | D_lesional_pre-dose | 253.06 | 58 |
GSM1296103 | E_lesional_pre-dose | 253.04 | 56 |
GSM1296078 | F_lesional_pre-dose | 378.09 | 64 |
GSM1296107 | G_lesional_pre-dose | 372.14 | 63 |
GSM1296109 | H_lesional_pre-dose | 363.59 | 62 |
GSM1296080 | I_lesional_pre-dose | 322.08 | 61 |
GSM1296090 | J_lesional_pre-dose | 287.36 | 59 |
GSM1296074 | K_lesional_pre-dose | 359.28 | 64 |
GSM1296111 | L_lesional_pre-dose | 246.91 | 55 |
GSM1296099 | M_lesional_pre-dose | 249.41 | 56 |
GSM1296086 | O_lesional_pre-dose | 322.52 | 61 |
GSM1296117 | P_lesional_pre-dose | 297.78 | 58 |
GSM1296113 | Q_lesional_pre-dose | 294.28 | 58 |
GSM1296096 | R_lesional_pre-dose | 259.81 | 57 |
GSM1296105 | S_lesional_pre-dose | 429 | 65 |
GSM1296098 | T_lesional_pre-dose | 394.67 | 63 |
GSM1296101 | U_lesional_pre-dose | 205.26 | 52 |
GSM1296121 | V_lesional_pre-dose | 296.01 | 59 |
GSM1296088 | W_lesional_pre-dose | 345.47 | 62 |
GSM1296082 | X_lesional_pre-dose | 305.88 | 61 |
GSM1296115 | Y_lesional_pre-dose | 261 | 56 |
GSM1296084 | Z_lesional_pre-dose | 366.65 | 63 |
GSM1296072 | B_lesional_day8 | 329.41 | 60 |
GSM1296069 | L_lesional_day8 | 306.16 | 58 |
GSM1296071 | P_lesional_day8 | 319.47 | 59 |
GSM1296070 | Y_lesional_day8 | 313.76 | 59 |
GSM1296073 | V_lesional_day8 | 360.34 | 63 |
GSM1296034 | A_lesional_day15 | 243.51 | 54 |
GSM1296041 | G_lesional_day15 | 313.37 | 60 |
GSM1296035 | R_lesional_day15 | 253.61 | 56 |
GSM1296038 | U_lesional_day15 | 261.68 | 57 |
GSM1296047 | B_lesional_day15 | 361.57 | 62 |
GSM1296039 | E_lesional_day15 | 313.43 | 60 |
GSM1296042 | H_lesional_day15 | 343.58 | 61 |
GSM1296043 | L_lesional_day15 | 324.78 | 59 |
GSM1296037 | M_lesional_day15 | 226.84 | 54 |
GSM1296046 | P_lesional_day15 | 354.77 | 61 |
GSM1296044 | Q_lesional_day15 | 412.28 | 64 |
GSM1296045 | Y_lesional_day15 | 341.43 | 60 |
GSM1296025 | C_lesional_day15 | 614.44 | 71 |
GSM1296033 | D_lesional_day15 | 295.05 | 59 |
GSM1296027 | I_lesional_day15 | 500.15 | 68 |
GSM1296032 | J_lesional_day15 | 277.69 | 57 |
GSM1296024 | K_lesional_day15 | 442.06 | 66 |
GSM1296031 | W_lesional_day15 | 265.12 | 56 |
GSM1296028 | X_lesional_day15 | 332.06 | 61 |
GSM1296029 | Z_lesional_day15 | 445.03 | 65 |
GSM1296026 | F_lesional_day15 | 344.65 | 62 |
GSM1296030 | O_lesional_day15 | 443.72 | 66 |
GSM1296040 | S_lesional_day15 | 157.91 | 48 |
GSM1296036 | T_lesional_day15 | 322.47 | 59 |
GSM1296048 | V_lesional_day15 | 256.87 | 56 |
GSM1296059 | A_lesional_day43 | 122.39 | 45 |
GSM1296066 | G_lesional_day43 | 342.92 | 61 |
GSM1296060 | R_lesional_day43 | 304.44 | 59 |
GSM1296063 | U_lesional_day43 | 279.33 | 58 |
GSM1296064 | E_lesional_day43 | 214.31 | 54 |
GSM1296067 | H_lesional_day43 | 403.43 | 63 |
GSM1296062 | M_lesional_day43 | 260.53 | 56 |
GSM1296068 | Q_lesional_day43 | 325.85 | 59 |
GSM1296050 | C_lesional_day43 | 552.05 | 70 |
GSM1296057 | D_lesional_day43 | 218.82 | 54 |
GSM1296052 | I_lesional_day43 | 405.44 | 65 |
GSM1296054 | J_lesional_day43 | 231.98 | 54 |
GSM1296049 | K_lesional_day43 | 596.3 | 71 |
GSM1296055 | W_lesional_day43 | 238.43 | 54 |
GSM1296053 | X_lesional_day43 | 356.38 | 62 |
GSM1296058 | Z_lesional_day43 | 175.67 | 51 |
GSM1296051 | F_lesional_day43 | 394.48 | 64 |
GSM1296056 | O_lesional_day43 | 196.07 | 53 |
GSM1296065 | S_lesional_day43 | 310.89 | 59 |
GSM1296061 | T_lesional_day43 | 375.47 | 62 |
GSM1296095 | A_non-lesional_pre-dose | 274.37 | 58 |
GSM1296120 | B_non-lesional_pre-dose | 364.39 | 62 |
GSM1296077 | C_non-lesional_pre-dose | 470.31 | 67 |
GSM1296093 | D_non-lesional_pre-dose | 271.8 | 57 |
GSM1296104 | E_non-lesional_pre-dose | 230.1 | 54 |
GSM1296079 | F_non-lesional_pre-dose | 639.73 | 72 |
GSM1296108 | G_non-lesional_pre-dose | 352.98 | 61 |
GSM1296110 | H_non-lesional_pre-dose | 408.52 | 63 |
GSM1296081 | I_non-lesional_pre-dose | 292.91 | 59 |
GSM1296091 | J_non-lesional_pre-dose | 301 | 60 |
GSM1296075 | K_non-lesional_pre-dose | 491.78 | 68 |
GSM1296112 | L_non-lesional_pre-dose | 349.88 | 60 |
GSM1296100 | M_non-lesional_pre-dose | 213.48 | 53 |
GSM1296087 | O_non-lesional_pre-dose | 468.94 | 67 |
GSM1296118 | P_non-lesional_pre-dose | 386.09 | 62 |
GSM1296114 | Q_non-lesional_pre-dose | 336.72 | 60 |
GSM1296097 | R_non-lesional_pre-dose | 346.89 | 61 |
GSM1296106 | S_non-lesional_pre-dose | 361.38 | 61 |
GSM1296102 | U_non-lesional_pre-dose | 304.4 | 58 |
GSM1296122 | V_non-lesional_pre-dose | 395.58 | 63 |
GSM1296089 | W_non-lesional_pre-dose | 221.55 | 53 |
GSM1296083 | X_non-lesional_pre-dose | 326.3 | 60 |
GSM1296116 | Y_non-lesional_pre-dose | 409.71 | 64 |
GSM1296085 | Z_non-lesional_pre-dose | 379.98 | 63 |